首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   110篇
  免费   9篇
  国内免费   2篇
儿科学   6篇
妇产科学   2篇
基础医学   11篇
口腔科学   1篇
临床医学   12篇
内科学   28篇
神经病学   9篇
特种医学   4篇
外科学   9篇
综合类   3篇
预防医学   17篇
眼科学   1篇
药学   5篇
中国医学   3篇
肿瘤学   10篇
  2024年   1篇
  2023年   2篇
  2022年   4篇
  2021年   8篇
  2020年   4篇
  2019年   5篇
  2018年   6篇
  2017年   4篇
  2016年   8篇
  2015年   14篇
  2014年   5篇
  2013年   10篇
  2012年   8篇
  2011年   15篇
  2010年   5篇
  2009年   2篇
  2008年   2篇
  2007年   2篇
  2006年   3篇
  2005年   3篇
  2004年   3篇
  2003年   2篇
  2000年   1篇
  1999年   1篇
  1985年   1篇
  1984年   1篇
  1979年   1篇
排序方式: 共有121条查询结果,搜索用时 15 毫秒
61.
Medicine, Health Care and Philosophy - With robots being introduced into caregiving, particularly for older persons, various ethical concerns are raised. Among them is the fear of replacing human...  相似文献   
62.
63.
Foot‐and‐mouth disease viruses are often restricted to specific geographical regions and spread to new areas may lead to significant epidemics. Phylogenetic analysis of sequences of the VP1 genome region of recent outbreak viruses from Libya and Saudi Arabia has revealed a lineage, O‐Ind‐2001, normally found in the Indian subcontinent. This paper describes the characterization of field viruses collected from these cases and provides information about a new real‐time RT‐PCR assay that can be used to detect viruses from this lineage and discriminate them from other endemic FMD viruses that are co‐circulating in North Africa and western Eurasia.  相似文献   
64.
65.
目的 探讨拉米夫定与恩替卡韦治疗藏族慢性乙型肝炎患者的临床疗效和安全性.方法 采用随机数字表法,将符合纳入标准的114例藏族慢性乙型肝炎患者随机分为两组:恩替卡韦组(ETV组,n=57)和拉米夫定(LVD组,n=57).恩替卡韦组给予恩替卡韦片0.5 mg,口服,1次/d;拉米夫定组给与拉米夫定片100 mg,口服,1次/d,两组分别治疗48周.于治疗前及治疗12、24、48周时点测定两组的ALT和HBV DNA值,记录ALT复常、HBV DNA转阴、HBeAg转阴及血清学转换的患者例数以及治疗过程中不良事件的发生情况.结果 与治疗前比较,两组患者治疗12、24、48周时ALT、HBV DNA定量值均下降;与LVD组比较,治疗12、24周时ETV组的ALT、HBV DNA定量值下降,ALT复常率、HBV DNA转阴率升高,差异有统计学意义(P<0.05).两组患者在治疗过程中均未发生严重不良反应事件.结论 拉米夫定与恩替卡韦治疗藏族慢性乙型肝炎患者安全、有效,但拉米夫定耐药性高,恩替卡韦在恢复肝功能及降低HBV复制的效果优于拉米夫定.  相似文献   
66.
Chronic myeloproliferative neoplasms (MPN) characteristically arise from a somatic mutation in the pluripotent hematopoietic stem cell, and most common recurring mutations are in the JAK2, CALR, and cMPL genes. However, these mutations are not founder mutations, but mainly drive the disease phenotype and a pre-existing germline predisposition has been long speculated, but has not been clearly defined to date. Genome-wide association studies in family clusters of MPN have identified a number of genetic variants that are associated with increased germline risk for developing clonal MPN. The strongest association discovered so far is the presence of JAK2 46/1 haplotype, and subsequently, many studies have found additional variants in other genes, most notably in TERT gene. However, these still account for a small fraction of familial MPN, and more in-depth studies including whole genome sequencing are needed to gain better insight into familial genetic predisposition of clonal MPNs.  相似文献   
67.
We report a molecular epidemiological study of rabies virus (RABV) strains circulating in animal populations in Bhutan, and investigate potential origins of these viruses. Twenty-three RABV isolates originating from dogs and other domestic animals were characterized by sequencing the partial nucleoprotein (N) gene (395 bp). Phylogenetic analysis was conducted and the Bhutanese isolates were compared with rabies viruses originating from other parts of the world. Phylogenetic analysis showed that Bhutanese isolates were highly similar and were closely related to Indian strains and South Asian Arctic-like-1 viruses. Our study suggests that the rabies viruses spreading in southern parts of Bhutan have originated from a common ancestor, perhaps from the Indian virus strain.  相似文献   
68.
69.

Purpose

The year 2015 status of eye care service profile in Southeast Asia countries was compared with year 2010 data to determine the state of preparedness to achieve the World Health Organization global action plan 2019.

Methods

Information was collected from the International Agency for Prevention of Blindness country chairs and from the recent PubMed referenced articles. The data included the following: blindness and low vision prevalence, national eye health policy, eye health expenses, presence of international non-governmental organizations, density of eye health personnel, and the cataract surgical rate and coverage. The last two key parameters were compared with year 2010 data.

Results

Ten of 11 country chairs shared the information, and 28 PubMed referenced publications were assessed. The prevalence of blindness was lowest in Bhutan and highest in Timor-Leste. Cataract surgical rate was high in India and Sri Lanka. Cataract surgical coverage was high in Thailand and Sri Lanka. Despite increase in number of ophthalmologists in all countries (except Timor-Leste), the ratio of the population was adequate (1:100,000) only in 4 of 10 countries (Bhutan, India, Maldives and Thailand), but this did not benefit much due to unequal urban–rural divide.

Conclusion

The midterm assessment suggests that all countries must design the current programs to effectively address both current and emerging causes of blindness. Capacity building and proportionate distribution of human resources for adequate rural reach along with poverty alleviation could be the keys to achieve the universal eye health by 2019.
  相似文献   
70.
OBJECTIVE: To examine the safety and feasibility of laparoscopically assisted vaginal hysterectomy (LAVH) for uteri weighing 500 g or more as compared to uteri weighing less than 500 g in the management of benign gynecological diseases. METHOD: In this prospective comparative study, 189 women with different benign gynecological diseases were scheduled for laparoscopically assisted vaginal hysterectomy. They were divided into two groups, with uterine weight greater than 500 g and uterine weight less than 500 g. Outcome measures for both the groups were studied comparatively in terms of length of operative time, amount of blood loss, requirement of blood transfusion and length of hospital stay. RESULTS: Length of operation and amount blood loss were significantly greater in the uteri >o r = 500 g group than in the <500 g at 91.1 +/- 28.7 min versus 77.4 +/- 26.6 min (P < 0.01), and 570.5 +/- 503.6 ml versus 262.5 +/- 270.0 ml (P < 0.001), respectively. However, there was no difference in length of hospital stay and overall incidence of operative complications between the two groups. None of the women had any major complications though 17 minor complications were noted. There was no incidence of switching to abdominal laparatomy during the operation except for one patient who required "minilaparotomy" for removal of large surgical specimen (2400 g). Extreme intra-operative hemorrhage of more than 1000 ml occurred in five patients, however, they made full recovery after blood transfusion. Rate of blood transfusion was significantly lower in the uteri <500 g group (4.8% versus 34.9%, (P < 0.001). CONCLUSION: This study demonstrates that despite the increased operating time and blood loss, LAVH can be safely performed for large uterus. However, surgeons need to be aware of the high risk of blood transfusion in these patients.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号